Therefore, future studies employing multi-level, multi-center, large-sample designs—incorporating subtype-specific stratified analyses and TME assessments—may better clarify the prognostic significance of TROP2 in lung cancer. This evidence concerns the gene TACSTD2 and lung cancer.